Thrombosis of sirolimus-eluting coronary stent in the postanesthesia care unit

Anesthesia and Analgesia

Volumn 101, Issue 4, 2005, Pages 971-973

  Murphy, J Thomas ^a   Fahy, Brenda G ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; EPTIFIBATIDE; RAPAMYCIN;

ADULT; ANGINA PECTORIS; ARTICLE; CASE REPORT; CORONARY ARTERY THROMBOSIS; CORONARY STENT; DRUG DELIVERY SYSTEM; DRUG ELUTING STENT; FEMALE; HEART CATHETERIZATION; HEART INFARCTION; HUMAN; HYSTERECTOMY; PERCUTANEOUS CORONARY INTERVENTION; PREOPERATIVE TREATMENT; PRIORITY JOURNAL;

EID: 25644459233     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ANE.0000175821.42010.9F     Document Type: Article

References (31)

1. Kaluza GL, Joseph J, Lee JR, et al. Catastrophic outcomes of noncardiac surgery soon after coronary stenting. J Am Coll Cardiol 2000;35:1288-94.
2. Vicenzi MN, Ribitsch D, Luha O, et al. Coronary artery stenting before noncardiac surgery: more threat than safety? Anesthesiology 2001;94:367-8.
3. Wilson SH, Fasseas P, Orford JL, et al. Clinical outcome of patients undergoing non-cardiac surgery in the two months following coronary stenting. J Am Coll Cardiol 2003;42:234-40.
4. Auer J, Berent R, Weber T, Eber B. Risk of noncardiac surgery in the months following placement of a drug-eluting coronary stent. J Am Coll Cardiol 2004;43:713.
5. Marcucci C, Chassot PG, Gardaz JP, et al. Fatal myocardial infarction after lung resection in a patient with prophylactic preoperative coronary stenting. Br J Anaesth 2004;92:743-7.
6. Sharma AK, Ajani AE, Hamwi SM, et al. Major noncardiac surgery following coronary stenting: when is it safe to operate? Catheter Cardiovasc Interv 2004;63:141-5.
7. Eagle KA, Berger PB, Calkins H, et al. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery-executive summary. A report of the American College of Cardiology/Am Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Anesth Analg 2002;94:1052-64.
8. Grewe PH, Deneke T, Machraoui A, et al. Acute and chronic tissue response to coronary stent implantation: pathologic findings in human specimen. J Am Coll Cardiol 2000;35:157-63.
9. Mehta SR, Yusuf S, Peters RJ, et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet 2001;358:527-33.
10. Arjomand H, Turi ZG, McCormick D, Goldberg S. Percutaneous coronary intervention: historical perspectives, current status, and future directions. Am Heart J 2003;146:787-96.
11. Posner KL, Van Norman GA, Chan V. Adverse cardiac outcomes after noncardiac surgery in patients with prior percutaneous transluminal coronary angioplasty. Anesth Analg 1999; 89:553-60.
12. Van Norman GA, Posner K. Coronary stenting or percutaneous transluminal coronary angioplasty prior to noncardiac surgery increases adverse perioperative cardiac events: the evidence is mounting. J Am Coll Cardiol 2000;36:2351-2.
13. Collet JP, Montalescot G, Blanchet B, et al. Impact of prior use or recent withdrawal of oral antiplatelet agents on acute coronary syndromes. Circulation 2004;110:2361-7.
14. McFadden EP, Stabile E, Regar E, et al. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet 2004;364:1519-21.
15. Orford JL, Lennon R, Melby S, et al. Frequency and correlates of coronary stent thrombosis in the modern era: analysis of a single center registry. J Am Coll Cardiol 2002;40:1567-72.
16. Wang F, Stouffer GA, Waxman S, Uretsky BF. Late coronary stent thrombosis: early vs. late stent thrombosis in the stent era. Catheter Cardiovasc Interv 2002;55:142-7.
17. Yusuf S, Zhao F, Mehta SR, et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001;345:494-502.
18. Rawitscher RE, Jones JW, McCoy TA, Lindsley DA. A prospective study of aspirin's effect on red blood cell loss in cardiac surgery. J Cardiovasc Surg 1991;32:1-7.
19. Reich DL, Patel GC, Vela-Cantos F, et al. Aspirin does not increase homologous blood requirements in elective coronary bypass surgery. Anesth Analg 1994;79:4-8.
20. Karabulut H, Toraman F, Evrenkaya S, et al. Clopidogrel does not increase bleeding and allogenic blood transfusion in coronary artery surgery. Eur J Cardio-thoracic Surg 2004;25:419-23.
21. Chu MW, Wilson SR, Novick RJ, et al. Does clopidogrel increase blood loss following coronary artery bypass surgery? Ann Thorac Surg 2004;78:1536-41.
22. Chen L, Bracey AW, Radovancevic R, et al. Clopidogrel and bleeding in patients undergoing elective coronary artery bypass grafting. J Thorac Cardiovasc Surg 2004;128:425-31.
23. Moore M, Power M. Perioperative hemorrhage and combined clopidogrel and aspirin therapy. Anesthesiology 2004;101: 792-4.
24. Satler LF. Recommendations regarding stent selection in relation to the timing of noncardiac surgery postpercutaneous coronary intervention. Catheter Cardiovasc Interv 2004;63:146-147.
25. Cohen M, Demers C, Gurfinkel EP, et al. A comparison of low molecular weight heparin with unfractionated heparin for unstable coronary artery disease. N Engl J Med 1997;337:447-52.
26. Goodman SG, Cohen M, Bigonzi F, et al. Randomized trial of low molecular weight heparin (enoxaparin) versus unfractionated heparin for unstable coronary artery disease: one-year results of the ESSENCE study. Efficacy and safety of subcutaneous enoxaparin in non-Q wave coronary events. J Am Coll Cardiol 2000;36:693-8.
27. Faxon DP, Spiro TE, Minor S, et al. Low molecular weight heparin in prevention of restenosis after angioplasty: results of enoxaparin restenosis (ERA) trial. Circulation 1994;90:908-14.
28. Kereiakes DJ, Grines C, Fry E, et al. Enoxaparin and abciximab adjunctive pharmacotherapy during percutaneous coronary intervention. J Invasive Card 2001;13:272-8.
29. Fléron MH, Dupuis M, Mottet P, et al. Non cardiac surgery in patient with coronary stenting: think sirolimus now [in French]! Ann Fr Anesth Reanim 2003;22:733-5.
30. Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction-executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Proactive Guidelines (Writing Committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction). Circulation 2004;110:588-636.
31. Steinhubl SR, Berger PB, Mann JT, et al. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention. JAMA 2002;288:2411-20.